PATENT CLAIM ANALYSIS

Application Number: 16210228
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-03
Patent Classification: ["424", "145100"]

Abstract:
A cell-based assay for assessing the functional activity of a canine or feline IL-31 inhibitor candidate is provided. Such a canine or feline IL-31 inhibitor candidate can be an isolated antibody that specifically binds to at least one of canine Interleukin-31 (IL-31) or feline IL-31. Such antibodies can be in the form of diagnostic and/or veterinary compositions useful for treating a pruritic and/or allergic condition in dogs or cats.

Claim (Index 13):
The cell-based assay of  claim 1 , wherein a canine or feline IL-31 inhibitor candidate that inhibits greater than 50% of the protein phosphorylation relative to the vehicle control is selected for further purification and/or characterization.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 98.0
- Lexical Diversity: 1.5102
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13536081', '14325541', '11149309', '15844142', '14405959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7993623086112318
- 35 USC 102 Novelty (BERT): 0.6151426495879315
- Combined Prediction Score: 0.7809403427089019
- Mean Citation Score: 468.31124000000005
- Max Citation Score: 702.1775
- Similarity Product: 470.1098405084014

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test